Li Z
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- RNA modifications and cancer 14
- Circular RNAs in diseases 10
- RNA Research and Splicing 7
-
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Mei Lin (6 shared papers)Yue‐zhong Li (8 shared papers)Fujin Wang (3 shared papers)Xiaoqian Feng (1 shared paper)Yonghong Wu (2 shared papers)Zhiyong Shen (3 shared papers)Wubin Qu (2 shared papers)Xingyi Hang (3 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Advanced Synthesis & Catalysis (2 papers)Journal of Bacteriology (2 papers)World Journal of Urology (2 papers)Blood (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Li Z
267 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 141
- Cancer Research 317
- Molecular Medicine 74
- Molecular Biology 907
- Endocrinology 46
- Immunology and Allergy 48
Countries citing papers authored by Li Z
This map shows the geographic impact of Li Z's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Z with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Z more than expected).
Fields of papers citing papers by Li Z
This network shows the impact of papers produced by Li Z. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Z. The network helps show where Li Z may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Z, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 286 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 127 | |
| 2 | 2013 | 99 | |
| 3 | 2021 | 93 | |
| 4 | 2015 | 69 | |
| 5 | 2006 | 57 | |
| 6 | 2008 | 53 | |
| 7 | 2009 | 44 | |
| 8 | 2016 | 43 | |
| 9 | 2011 | 41 | |
| 10 | 2023 | 40 | |
| 11 | Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCC. | 2018 | 34 |
| 12 | 2005 | 32 | |
| 13 | 2010 | 26 | |
| 14 | Human immunodeficiency virus load. Quantitative assessment in semen from seropositive individuals and in spiked seminal plasma. | 1995 | 23 |
| 15 | 2020 | 23 | |
| 16 | 2023 | 22 | |
| 17 | 2015 | 22 | |
| 18 | 2018 | 22 | |
| 19 | [Susceptibility to lung cancer in Chinese is associated with genetic polymorphism in cytochrome P4502E1]. | 2000 | 22 |
| 20 | 2019 | 21 |
About Li Z
Li Z is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Epidemiology, having authored 286 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (23 papers), RNA modifications and cancer (14 papers), MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (10 papers), Liver Disease Diagnosis and Treatment (10 papers), Hepatitis B Virus Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Cancer Research (317 citations), Molecular Medicine (74 citations), Molecular Biology (907 citations), Endocrinology (46 citations) and Immunology and Allergy (48 citations). Li Z has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Mei Lin, Yue‐zhong Li, Fujin Wang, Xiaoqian Feng, Yonghong Wu, Zhiyong Shen, Wubin Qu, Xingyi Hang, Chenggang Zhang and Wei Hu. Their work appears in journals such as Frontiers in Oncology, Advanced Synthesis & Catalysis, Journal of Bacteriology, World Journal of Urology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.